+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

From
Trigeminal Neuralgia Market Report and Forecast 2025-2034 - Product Thumbnail Image

Trigeminal Neuralgia Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Infantile Spasms Therapeutics Market 2025-2029 - Product Thumbnail Image

Infantile Spasms Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 201 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Fragile X Syndrome: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Fragile X Syndrome: Opportunity Assessment and Forecast - Update

  • Report
  • February 2025
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more